QA: Bellicum Pharmaceuticals INC in us_pharma/2016

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001358403_2017_Bellicum_Pharmaceuticals_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001358403, Bellicum Pharmaceuticals INC

  xvar xval
0 AssetsCurrent 105,610,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 16,504,000
3 remainder_Assets 9,923,000
4 LiabilitiesCurrent 15,113,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 20,350,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 16,925,000
9 ResearchAndDevelopmentExpense 51,263,000
10 remainder_Expenses 580,000
11 remainder_Revenues 388,000
12 remainder_NetIncome -861,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 132,037,000
1 Liabilities 35,463,000
2 Expenses 68,768,000
3 Revenues 388,000
4 StockholdersEquity 96,574,000
5 NetIncome -69,241,000
6 ComprehensiveNetIncome -69,241,000
7 BaseVar 118,758,500
8 EconomicCapitalRatiobeforeLimitedLiability 1.69
9 EconomicCapitalRatio 2.81

Edgar->Model Mapping

Feature Distribution

Change over Time